CMR Surgical

CMR Surgical is a Cambridge, UK-based global medical device company focused on robotic-assisted surgery. Its Versius system is used for minimally invasive soft-tissue procedures in hospitals worldwide, and the company is developing next-generation surgical robotics. In October 2026 it formed a strategic alliance with Stryker, which invested approximately $400M in preferred equity, gained US sales rights and an exclusive option to acquire the company.

  • Series C+
  • Robotics
  • Healthtech
  • Medical Devices
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Oct 12, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Oct 12, 2026

    $400M

    Series C+

    Led by Stryker

    • Stryker

    Article coming soon.

Pricing

Research CMR Surgical — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if CMR Surgical is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational